Alkaline Buffers Release EDRF from Bovine Cultured Aortic Endothelial Cells

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 1991 Jun 1

PMID 1884092

Citations 6

Authors

J A Mitchell

G De Nucci

T D Warner

J R Vane

Affiliations

Soon will be listed here.

Abstract

1. Release of endothelium-derived relaxing factor (EDRF) and prostacyclin (PGI2) from bovine cultured aortic endothelial cells (EC) was measured by bioassay and radioimmunoassay, respectively. 2. Bradykinin (BK, 3-30 pmol), adenosine diphosphate (ADP, 2-6 nmol) or the sodium ionophore monensin (40-100 nmol) injected through a column of EC released EDRF. L-Arginine free base (FB; 10-20 mumol) or D-arginine FB (10-20 mumol) injected through the column of EC released similar amounts of EDRF and also caused an increase in pH of the Krebs solution perfusing the EC from 7.5-8.0 to 8.6-9.5. Sodium carbonate (Na2CO3) an alkaline buffer which caused the same changes in the pH of the Krebs solution also induced the same release of EDRF. The hydrochloride salts of L- or D-arginine did not cause either release of EDRF when injected through the column of EC or increases in the pH of the Krebs solution. 3. Inhibitors of either diacylglycerol lipase (RHC 80267) or kinase (R59022) inhibited the release of EDRF induced by BK or ADP but potentiated the release induced by L-arginine FB, monensin (40-100 nmol) or alkaline buffer (Na2CO3). R59022 and RHC 80267 infused through the EC increased the basal release of EDRF. 4. When calcium chloride was omitted from the Krebs solution the release of EDRF induced by alkaline buffer (Na2CO3; pH 8.6-9.5) or L-arginine FB (10-20 mumol) was selectively inhibited when compared to that induced by BK (3-30 pmol) or ADP (2-6 nmol). This inhibition was reversed when calcium (2.5 mM) was restored. 5. NG-monomethyl-L-arginine (NMMA; 30 microM) inhibited release of EDRF induced by BK (10-30 pmol) or alkaline buffers (Na2CO3 or D-arginine FB; pH 8.6-9.5). This inhibition was partially reversed by L- but not D-arginine FB or HCl (30-100 microM). 6. Prostacyclin was released when BK (10 pmol), ADP (2 nmol) or arachidonic acid (30 nmol) were injected through the column of EC. However, monensin (40 nmol) or alkaline buffers (pH 8.6-9.5) did not release detectable amounts of PGI2 as measured by radioimmunoassay for 6-oxo-prostaglandin F1 alpha. 7. Thus alkalinisation of the external bathing solution can release EDRF from cultured EC by a mechanism which does not involve receptor activation and which depends on the presence of extracellular calcium.

Citing Articles

The effect of extracellular pH changes on intracellular pH and nitric oxide concentration in endothelial and smooth muscle cells from rat aorta.

Capellini V, Restini C, Bendhack L, Evora P, Celotto A PLoS One. 2013; 8(5):e62887.

PMID: 23690964 PMC: 3656859. DOI: 10.1371/journal.pone.0062887.

Changes in extracellular pH and myocardial ischaemia alter the cardiac effects of diadenosine tetraphosphate and pentaphosphate.

Stavrou B, Beck C, Flores N Br J Pharmacol. 2001; 134(3):639-47.

PMID: 11588119 PMC: 1572982. DOI: 10.1038/sj.bjp.0704288.

Divergent effects of extracellular and intracellular alkalosis on Ca2+ entry pathways in vascular endothelial cells.

Wakabayashi I, Groschner K Biochem J. 1997; 323 ( Pt 2):567-73.

PMID: 9163353 PMC: 1218356. DOI: 10.1042/bj3230567.

Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids.

Swierkosz T, Mitchell J, Warner T, Botting R, Vane J Br J Pharmacol. 1995; 114(7):1335-42.

PMID: 7541688 PMC: 1510271. DOI: 10.1111/j.1476-5381.1995.tb13353.x.

Role of nitric oxide in modulating permeability of hamster cheek pouch in response to adenosine 5'-diphosphate and bradykinin.

Mayhan W Inflammation. 1992; 16(4):295-305.

PMID: 1526662 DOI: 10.1007/BF00917622.

References

Vane J . Prostaglandin research. Eicosanoids. 1988; 1(1):1-2. View

Salmon J . A radioimmunoassay for 6-keto-prostaglandin F1alpha. Prostaglandins. 1978; 15(3):383-97. DOI: 10.1016/0090-6980(78)90122-3. View

Marletta M, Yoon P, Iyengar R, Leaf C, Wishnok J . Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988; 27(24):8706-11. DOI: 10.1021/bi00424a003. View

Vane J . THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964; 23:360-73. PMC: 1704098. DOI: 10.1111/j.1476-5381.1964.tb01592.x. View

Schmidt H, Nau H, Wittfoht W, Gerlach J, Prescher K, Klein M . Arginine is a physiological precursor of endothelium-derived nitric oxide. Eur J Pharmacol. 1988; 154(2):213-6. DOI: 10.1016/0014-2999(88)90101-x. View

Stuehr D, Gross S, Sakuma I, Levi R, Nathan C . Activated murine macrophages secrete a metabolite of arginine with the bioactivity of endothelium-derived relaxing factor and the chemical reactivity of nitric oxide. J Exp Med. 1989; 169(3):1011-20. PMC: 2189276. DOI: 10.1084/jem.169.3.1011. View

Nucci G, Gryglewski R, Warner T, Vane J . Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci U S A. 1988; 85(7):2334-8. PMC: 279986. DOI: 10.1073/pnas.85.7.2334. View

Gryglewski R, Moncada S, Palmer R . Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells. Br J Pharmacol. 1986; 87(4):685-94. PMC: 1916807. DOI: 10.1111/j.1476-5381.1986.tb14586.x. View

Gryglewski R, Palmer R, Moncada S . Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature. 1986; 320(6061):454-6. DOI: 10.1038/320454a0. View

10.

Forstermann U, Frolich J, Busse R . Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor. J Pharmacol Exp Ther. 1986; 238(1):352-9. View

11.

Mulsch A, Bohme E, Busse R . Stimulation of soluble guanylate cyclase by endothelium-derived relaxing factor from cultured endothelial cells. Eur J Pharmacol. 1987; 135(2):247-50. DOI: 10.1016/0014-2999(87)90620-0. View

12.

Madshus I . Regulation of intracellular pH in eukaryotic cells. Biochem J. 1988; 250(1):1-8. PMC: 1148806. DOI: 10.1042/bj2500001. View

13.

Palmer R, Ashton D, Moncada S . Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988; 333(6174):664-6. DOI: 10.1038/333664a0. View

14.

Palmer R, Ferrige A, Moncada S . Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327(6122):524-6. DOI: 10.1038/327524a0. View

15.

Smith C, Uhing R, Snyderman R . Nucleotide regulatory protein-mediated activation of phospholipase C in human polymorphonuclear leukocytes is disrupted by phorbol esters. J Biol Chem. 1987; 262(13):6121-7. View

16.

Hibbs Jr J, Vavrin Z, Taintor R . L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol. 1987; 138(2):550-65. View

17.

de Chaffoy de Courcelles D, Roevens P, Van Belle H . R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet. J Biol Chem. 1985; 260(29):15762-70. View

18.

Derian C, Moskowitz M . Polyphosphoinositide hydrolysis in endothelial cells and carotid artery segments. Bradykinin-2 receptor stimulation is calcium-independent. J Biol Chem. 1986; 261(8):3831-7. View

19.

Iyengar R, Stuehr D, Marletta M . Macrophage synthesis of nitrite, nitrate, and N-nitrosamines: precursors and role of the respiratory burst. Proc Natl Acad Sci U S A. 1987; 84(18):6369-73. PMC: 299077. DOI: 10.1073/pnas.84.18.6369. View

20.

Hibbs Jr J, Taintor R, Vavrin Z, Rachlin E . Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988; 157(1):87-94. DOI: 10.1016/s0006-291x(88)80015-9. View